60-Year-Old Drug May Hold Clues To Stopping Spread Of Breast Cancer

One of the oldest chemotherapy drugs in the world may be able to stop breast cancer spreading, according to a new study.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Source Type: news

Related Links:

The trial, at hundreds of sites in 41 countries, followed 902 patients and studied the combination of immunotherapy and chemotherapy
Source: Health News: CBSNews.com - Category: Consumer Health News Source Type: news
A combination of chemotherapy and antibody medication extended the lives of people with triple-negative breast cancer by up to 10 months in a new trial.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news
The trial, at hundreds of sites in 41 countries, followed 902 patients and studied the combination of immunotherapy and chemotherapy
Source: Health News: CBSNews.com - Category: Consumer Health News Source Type: news
New research is bringing hope to women with a hard-to-treat type of breast cancer. A study published over the weekend in the New England Journal of Medicine found that combining chemotherapy with an immunotherapy medicine added up to 10 months of survival time for patients with triple-negative breast cancer. Dr. David Agus joins "CBS This Morning" with more on the research.
Source: Health News: CBSNews.com - Category: Consumer Health News Source Type: news
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: Immunotherapy-Chemo Combo Extends Lives of Women With Aggressive Breast Cancer Treatment with immunotherapy plus chemotherapy extended the...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
ConclusionsDespite optimal management of diarrhea including treatment of grade I symptoms, it was not possible to treat the patients above a dose of 20  mg of afatinib daily in combination with 3-weekly trastuzumab. The MTD of afatinib in combination with the recommended 3-weekly dose of trastuzumab was 20 mg daily.
Source: Cancer Chemotherapy and Pharmacology - Category: Cancer & Oncology Source Type: research
Authors: Sang MM, Liu FL, Wang Y, Luo RJ, Huan XX, Han LF, Zhang ZT, Feng F, Qu W, Liu W, Zheng F Abstract Gambogic acid (GA) is a naturally derived potent anticancer agent with extremely poor biocompatibility. In the present study, a novel of redox/pH dual-responsive multifunctional magnetic complex micelle (sPEG/HA/CSO-SS-Hex/Fe3O4/GA), which consisted of a reducible hexadecanol-modified chitosan oligosaccharide polymer micelle (CSO-SS-Hex) coated with hyaluronic acid (HA) and DCA grafted sheddable PEG-PLL (sPEG) copolymers and loaded with gambogic acid (GA) and Fe3O4 nanoparticles were developed for parenteral d...
Source: Drug Delivery - Category: Drugs & Pharmacology Tags: Drug Deliv Source Type: research
Publication date: November 2018Source: Academic Radiology, Volume 25, Issue 11Author(s): Rossella Rella, Paolo Belli, Michela Giuliani, Enida Bufi, Giorgio Carlino, Pierluigi Rinaldi, Riccardo ManfrediAutomated breast ultrasonography (ABUS) is a new imaging technology for automatic breast scanning through ultrasound. It was first developed to overcome the limitation of operator dependency and lack of standardization and reproducibility of handheld ultrasound. ABUS provides a three-dimensional representation of breast tissue and allows images reformatting in three planes, and the generated coronal plane has been suggested t...
Source: Academic Radiology - Category: Radiology Source Type: research
In conclusion, the results of the present study revealed that HDAC inhibitors increase the sensitivity to 5-FU in 5-FU-sensitive and -resistant cells. PMID: 30333885 [PubMed]
Source: Oncology Letters - Category: Cancer & Oncology Tags: Oncol Lett Source Type: research
The trial, at hundreds of sites in 41 countries, followed 902 patients and studied the combination of immunotherapy and chemotherapy
Source: Health News: CBSNews.com - Category: Consumer Health News Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Pharmaceuticals | Study